DEXTROMETHORPHAN\GUAIFENESIN: 427 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
427
Total FAERS Reports
26 (6.1%)
Deaths Reported
50
Hospitalizations
427
As Primary/Secondary Suspect
6
Life-Threatening
First Report: 19921019 · Latest Report: 20250322
What Are the Most Common DEXTROMETHORPHAN\GUAIFENESIN Side Effects?
#1 Most Reported
Drug ineffective
64 reports (15.0%)
#2 Most Reported
Dizziness
48 reports (11.2%)
#3 Most Reported
Wrong technique in product usage process
44 reports (10.3%)
All DEXTROMETHORPHAN\GUAIFENESIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 64 | 15.0% | 0 | 2 |
| Dizziness | 48 | 11.2% | 0 | 2 |
| Wrong technique in product usage process | 44 | 10.3% | 0 | 0 |
| Diarrhoea | 41 | 9.6% | 0 | 4 |
| Nausea | 33 | 7.7% | 0 | 5 |
| Product size issue | 29 | 6.8% | 0 | 0 |
| Feeling abnormal | 28 | 6.6% | 0 | 1 |
| Vomiting | 22 | 5.2% | 0 | 4 |
| Extra dose administered | 21 | 4.9% | 0 | 0 |
| Serotonin syndrome | 19 | 4.5% | 0 | 17 |
| Product use complaint | 18 | 4.2% | 0 | 0 |
| Toxicity to various agents | 18 | 4.2% | 11 | 11 |
| Accidental overdose | 17 | 4.0% | 1 | 1 |
| Choking | 15 | 3.5% | 0 | 0 |
| Headache | 15 | 3.5% | 0 | 1 |
| Abdominal discomfort | 13 | 3.0% | 0 | 0 |
| Drug abuse | 13 | 3.0% | 1 | 6 |
| Insomnia | 12 | 2.8% | 0 | 0 |
| Abdominal pain upper | 11 | 2.6% | 0 | 0 |
| Completed suicide | 11 | 2.6% | 11 | 3 |
Who Reports DEXTROMETHORPHAN\GUAIFENESIN Side Effects? Age & Gender Data
Gender: 58.2% female, 41.8% male. Average age: 57.0 years. Most reports from: US. View detailed demographics →
Is DEXTROMETHORPHAN\GUAIFENESIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 1 | 0 | 0 |
| 2013 | 2 | 0 | 0 |
| 2014 | 14 | 0 | 1 |
| 2015 | 15 | 1 | 2 |
| 2016 | 34 | 1 | 1 |
| 2017 | 16 | 0 | 5 |
| 2018 | 6 | 0 | 0 |
| 2019 | 18 | 0 | 0 |
| 2020 | 18 | 1 | 2 |
| 2021 | 4 | 0 | 2 |
| 2022 | 21 | 2 | 2 |
| 2023 | 28 | 5 | 0 |
| 2024 | 21 | 0 | 0 |
| 2025 | 2 | 0 | 0 |
What Is DEXTROMETHORPHAN\GUAIFENESIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 175 |
| Cough | 94 |
| Nasopharyngitis | 30 |
| Nasal congestion | 23 |
| Secretion discharge | 21 |
| Upper respiratory tract infection | 17 |
| Respiratory tract congestion | 14 |
| Productive cough | 13 |
| Sinusitis | 10 |
| Pulmonary congestion | 9 |
DEXTROMETHORPHAN\GUAIFENESIN vs Alternatives: Which Is Safer?
DEXTROMETHORPHAN\GUAIFENESIN vs DEXTROSE
DEXTROMETHORPHAN\GUAIFENESIN vs DEXTROSE\DEXTROSE
DEXTROMETHORPHAN\GUAIFENESIN vs DEXTROSE\DEXTROSE\DOBUTAMINE\DOBUTAMINE
DEXTROMETHORPHAN\GUAIFENESIN vs DEXTROSE\HEPARIN
DEXTROMETHORPHAN\GUAIFENESIN vs DEXTROSE\LIDOCAINE
DEXTROMETHORPHAN\GUAIFENESIN vs DEXTROSE\SODIUM
DEXTROMETHORPHAN\GUAIFENESIN vs DIACETYLMORPHINE
DEXTROMETHORPHAN\GUAIFENESIN vs DIAMORPHINE
DEXTROMETHORPHAN\GUAIFENESIN vs DIATRIZOATE MEGLUMINE\DIATRIZOATE
DEXTROMETHORPHAN\GUAIFENESIN vs DIAZEPAM
Official FDA Label for DEXTROMETHORPHAN\GUAIFENESIN
Official prescribing information from the FDA-approved drug label.